awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43563722-C23FE815-3453-4F08-8797-085E469B0050
Q43563722-C23FE815-3453-4F08-8797-085E469B0050
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43563722-C23FE815-3453-4F08-8797-085E469B0050
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study.
P2860
Q43563722-C23FE815-3453-4F08-8797-085E469B0050
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43563722-C23FE815-3453-4F08-8797-085E469B0050
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b563939491846b48eccbd0e4b665643f5aa9a93
P2860
A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.